SPI Pharma Expands Mannogem® Mannitol Product Portfolio to support the development, manufacture and administration of oral dosage forms.
- Tuesday, March 24, 2020, 7:22
- Business
- Add a comment
WILMINGTON, Del., March 24, 2020 /PRNewswire/ — SPI Pharma has announced an expansion of its line of Mannogem Mannitol products for use in multiple patient-friendly oral dosage forms to now include: Mannogem XL Opal, Mannogem XL Ruby, Mannogem Emerald, and Mannogem Onyx. SPI Pharma has…
About the Author
adminasapcorp has written 39063 stories on this site.